1. Home
  2. LEGN vs PI Comparison

LEGN vs PI Comparison

Compare LEGN & PI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • PI
  • Stock Information
  • Founded
  • LEGN 2014
  • PI 2000
  • Country
  • LEGN United States
  • PI United States
  • Employees
  • LEGN N/A
  • PI N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • PI Industrial Machinery/Components
  • Sector
  • LEGN Health Care
  • PI Technology
  • Exchange
  • LEGN Nasdaq
  • PI Nasdaq
  • Market Cap
  • LEGN 6.3B
  • PI 5.8B
  • IPO Year
  • LEGN 2020
  • PI 2016
  • Fundamental
  • Price
  • LEGN $32.30
  • PI $241.55
  • Analyst Decision
  • LEGN Strong Buy
  • PI Buy
  • Analyst Count
  • LEGN 12
  • PI 7
  • Target Price
  • LEGN $70.82
  • PI $189.43
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • PI 503.3K
  • Earning Date
  • LEGN 11-11-2025
  • PI 10-29-2025
  • Dividend Yield
  • LEGN N/A
  • PI N/A
  • EPS Growth
  • LEGN N/A
  • PI N/A
  • EPS
  • LEGN N/A
  • PI N/A
  • Revenue
  • LEGN $796,838,000.00
  • PI $358,938,000.00
  • Revenue This Year
  • LEGN $70.27
  • PI $0.03
  • Revenue Next Year
  • LEGN $50.28
  • PI $23.02
  • P/E Ratio
  • LEGN N/A
  • PI N/A
  • Revenue Growth
  • LEGN 74.75
  • PI 13.96
  • 52 Week Low
  • LEGN $27.34
  • PI $60.85
  • 52 Week High
  • LEGN $47.79
  • PI $247.06
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.99
  • PI 70.17
  • Support Level
  • LEGN $31.44
  • PI $231.41
  • Resistance Level
  • LEGN $32.59
  • PI $247.06
  • Average True Range (ATR)
  • LEGN 1.36
  • PI 12.37
  • MACD
  • LEGN 0.11
  • PI 3.94
  • Stochastic Oscillator
  • LEGN 37.97
  • PI 91.16

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

Share on Social Networks: